Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

AVNS - Avanos Medical Inc Stock Price, Fair Value and News

$11.31-0.04 (-0.35%)
Delayed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

AVNS Price Action

Last 7 days

-4.5%

Last 30 days

1.0%

Last 90 days

-10.7%

Trailing 12 Months

-40.6%

AVNS RSI Chart

MarAprMayJunJulAugSepOctNovDec102030405060708090

AVNS Valuation

Market Cap

525.0M

Price/Earnings (Trailing)

-1.12

Price/Sales (Trailing)

0.75

EV/EBITDA

-1.22

Price/Free Cashflow

5.03

AVNS Price/Sales (Trailing)

20232024202511.52

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

AVNS Fundamentals

AVNS Revenue

Revenue (TTM)

699.9M

Rev. Growth (Yr)

4.34%

Rev. Growth (Qtr)

1.6%

201420162018202020222024600M800M1B1.2B1.4B1.6B

AVNS Earnings

Earnings (TTM)

-468.9M

Earnings Growth (Yr)

-132.56%

Earnings Growth (Qtr)

98.18%

201420162018202020222024-500M-400M-300M-200M-100M0100M200M

AVNS Profitability

EBT Margin

-69.71%

Return on Equity

-60.27%

Return on Assets

-43.92%

Free Cashflow Yield

19.89%

AVNS Investor Care

Shares Dilution (1Y)

1.01%

Diluted EPS (TTM)

-10.19

AVNS Alerts

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
201420162018202020222024600M800M1B1.2B1.4B1.6B
Net sales
YearQ1Q2Q3Q4
2025689.2M692.5M699.9M0
2024680.1M682.4M681.5M687.8M
2023665.0M663.5M662.5M673.3M
2022603.7M588.2M576.4M703.1M
2021715.1M737.8M736.2M587.0M
2020713.8M705.3M719.6M714.8M
2019660.1M671.4M677.7M697.6M
2018622.3M634.1M648.7M652.3M
2017577.5M588.9M600.3M611.6M
2016523.3M537.6M551.9M566.2M
20151.7B1.6B1.6B509.0M
20141.7B1.7B1.7B1.7B
2013001.7B1.7B
20120001.7B
Get all data in R, Python etc through our Historical Stock Data APIs

About Avanos Medical Inc

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy and OrthogenRx's knee osteoarthritis pain relief injection products. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
 CEO
 WEBSITEhttps://avanos.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES4044

Avanos Medical Inc Frequently Asked Questions

What is the ticker symbol for Avanos Medical Inc? What does AVNS stand for in stocks?

AVNS is the stock ticker symbol of Avanos Medical Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Avanos Medical Inc (AVNS)?

As of Wed Dec 03 2025, market cap of Avanos Medical Inc is 525 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AVNS stock?

You can check AVNS's fair value in chart for subscribers.

Is Avanos Medical Inc a good stock to buy?

The fair value guage provides a quick view whether AVNS is over valued or under valued. Whether Avanos Medical Inc is cheap or expensive depends on the assumptions which impact Avanos Medical Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AVNS.

What is Avanos Medical Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, AVNS's PE ratio (Price to Earnings) is -1.12 and Price to Sales (PS) ratio is 0.75. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AVNS PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Avanos Medical Inc's stock?

In the past 10 years, Avanos Medical Inc has provided -0.103 (multiply by 100 for percentage) rate of return.